Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer

Cancer Epidemiology

Volumn 34, Issue 2, 2010, Pages 142-149

  Conlon, Michael S C ^a   Johnson, Kenneth C ^b   Bewick, Mary A ^a   Lafrenie, Robert M ^c   Donner, Allan ^d  

^a Outcomes and Evaluation Research   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c SUDBURY REGIONAL HOSPITAL   (Canada)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

Active smoking; Breast neoplasms; Case control study; NAT2; Tobacco smoke pollution

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; NAT2 PROTEIN, HUMAN; PASSIVE SMOKING;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER RISK; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PASSIVE SMOKING; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; BREAST NEOPLASMS; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 77950301217     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.02.001     Document Type: Article

References (54)

1. Canadian Cancer Society/National Cancer Institiute of Canada: Canadian Cancer Statistics 2008, Toronto, Canada, 2008.
2. Rockhill B., Weinberg C.R., and Newman B. Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol 147 (1998) 826-833
3. Seidman H., Stellman S.D., and Mushinski M.H. A different perspective on breast cancer risk factors: some implications of the nonattributable risk. CA Cancer J Clin 32 (1982) 301-313
4. Madigan M.P., Ziegler R.G., Benichou J., Byrne C., and Hoover R.N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87 (1995) 1681-1685
5. Palmer J.R., and Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 15 (1993) 145-156
6. Hamajima N., Hirose K., Tajima K., Rohan T., Calle E.E., Heath Jr. C.W., et al. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87 (2002) 1234-1245
7. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: tobacco smoke and involuntary smoking vol. 83 (2004), International Agency for Research on Cancer, Lyon, France
8. Johnson K.C. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 117 (2005) 619-628
9. Collishaw N.E., Boyd N.F., Cantor K.P., Hammond S.K., Johnson K.C., Millar J., et al. Canadian expert panel on tobacco smoke and breast cancer risk (April 2009), Ontario Tobacco Research Unit, Toronto, Canada. http://www.otru.org/pdf/special/expert_panel_tobacco_breast_cancer.pdf OTRU special report series [accessed 20.12.09]
10. Terry P.D., and Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 602-611
11. Ambrosone C.B., Kropp S., Yang J., Yao S., Shields P.G., and Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008)
12. Johnson K.C., Hu J., and Mao Y. Passive and active smoking and breast cancer risk in Canada, 1994-97. Cancer Causes Control 11 (2000) 211-221
13. Morabia A., Bernstein M., Heritier S., and Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 143 (1996) 918-928
14. Band P., Le N., Fang R., and Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360 (2002) 1044
15. Hein D.W. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25 (2006) 1649-1658
16. Krajinovic M., Richer C., Sinnett H., Labuda D., and Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 9 (2000) 557-562
17. dos Santos Silva I. Cancer epidemiology: principles and methods (1999), International Agency for Research on Cancer, Lyon, France
18. Selvin S. A note on the power to detect interaction effects. In: Kelsey J., Marmot M., Stolley P., and Vessey M. (Eds). Statistical analysis of epidemiologic data. 2nd ed. (2007), Oxford University Press, Oxford 213-214
19. Hein D.W., Ferguson R.J., Doll M.A., Rustan T.D., and Gray K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 3 (1994) 729-734
20. van der Hel O.L., Peeters P.H., Hein D.W., Doll M.A., Grobbee D.E., Kromhout D., et al. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 13 (2003) 399-407
21. Smith S.J., Deacon J.M., and Chilvers C.E. Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. Br J Cancer 70 (1994) 112-119
22. Zhao Y., Shi Z., and Liu L. Matched case-control study for detecting risk factors of breast cancer in women living in Chengdu. Zhonghua Liu Xing Bing Xue Za Zhi 20 (1999) 91-94
23. Kropp S., and Chang-Claude J. Active and passive smoking and risk of breast cancer by age 50 years among german women. Am J Epidemiol 156 (2002) 616-626
24. Morabia A., Bernstein M.S., Bouchardy I., Kurtz J., and Morris M.A. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol 152 (2000) 226-232
25. Chang-Claude J., Kropp S., Jager B., Bartsch H., and Risch A. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 698-704
26. Sillanpaa P., Hirvonen A., Kataja V., Eskelinen M., Kosma V.M., Uusitupa M., et al. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer (2004)
27. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83, 2003. Tobacco smoking and tobacco smoke (2002)
28. Luceri F., Pieraccini G., Moneti G., and Dolara P. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol Ind Health 9 (1993) 405-413
29. Palmiotto G., Pieraccini G., Moneti G., and Dolara P. Determination of the levels of aromatic amines in indoor and outdoor air in Italy. Chemosphere 43 (2001) 355-361
30. Airoldi L., Vineis P., Colombi A., Olgiati L., Dell'Osta C., Fanelli R., et al. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiol Biomarkers Prev 14 (2005) 2118-2124
31. Vineis P., Bartsch H., Caporaso N., Harrington A.M., Kadlubar F.F., Landi M.T., et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369 (1994) 154-156
32. Egan K.M., Stampfer M.J., Hunter D., Hankinson S., Rosner B.A., Holmes M., et al. Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology 13 (2002) 138-145
33. Reynolds P., Hurley S., Goldberg D.E., Anton-Culver H., Bernstein L., Deapen D., et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96 (2004) 29-37
34. Li C.I., Malone K.E., and Daling J.R. The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States). Cancer Causes Control 16 (2005) 975-985
35. Gram I.T., Braaten T., Terry P.D., Sasco A.J., Adami H.O., Lund E., et al. Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14 (2005) 61-66
36. Millikan R.C., Pittman G.S., Newman B., Tse C.K., Selmin O., Rockhill B., et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7 (1998) 371-378
37. Calle E.E., Miracle-McMahill H.L., Thun M.J., and Heath Jr. C.W. Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 139 (1994) 1001-1007
38. Terry P.D., Miller A.B., and Rohan T.E. Cigarette smoking and breast cancer risk: a long latency period?. Int J Cancer 100 (2002) 723-728
39. Cui Y., Miller A.B., and Rohan T.E. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat 100 (2006) 293-299
40. Krajinovic M., Ghadirian P., Richer C., Sinnett H., Gandini S., Perret C., et al. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 92 (2001) 220-225
41. Van Der Hel O.L., Bueno-de-Mesquita H.B., van Gils C.H., Roest M., Slothouber B., Grobbee D.E., et al. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). Cancer Causes Control 16 (2005) 675-681
42. Kocabas N.A., Sardas S., Cholerton S., Daly A.K., and Karakaya A.E. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Int J Toxicol 23 (2004) 25-31
43. Delfino R.J., Smith C., West J.G., Lin H.J., White E., Liao S.Y., et al. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics 10 (2000) 461-469
44. Hunter D.J., Hankinson S.E., Hough H., Gertig D.M., Garcia-Closas M., Spiegelman D., et al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 18 (1997) 2127-2132
45. Egan K.M., Newcomb P.A., Titus-Ernstoff L., Trentham-Dietz A., Mignone L.I., Farin F., et al. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control 14 (2003) 43-51
46. Ambrosone C.B., Freudenheim J.L., Marshall J.R., Graham S., Vena J.E., Brasure J.R., et al. The association of polymorphic N-acetyltransferase (NAT2) with breast cancer risk. Ann N Y Acad Sci 768 (1995) 250-252
47. Ambrosone C.B., Freudenheim J.L., Graham S., Marshall J.R., Vena J.E., Brasure J.R., et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276 (1996) 1494-1501
48. Alberg A.J., Daudt A., Huang H.Y., Hoffman S.C., Comstock G.W., Helzlsouer K.J., et al. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev 28 (2004) 187-193
49. Lissowska J., Brinton L.A., Zatonski W., Blair A., Bardin-Mikolajczak A., Peplonska B., et al. Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer 119 (2006) 1961-1969
50. Vineis P., and McMichael A. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control 7 (1996) 479-486
51. Peluso M., Castegnaro M., Malaveille C., Friesen M., Garren L., Hautefeuille A., et al. 32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis 12 (1991) 713-717
52. Morabia A., Lash T., and Aschengrau A. Passive cigarette smoking and breast cancer. In: Watson R.R., and Witten M. (Eds). Environmental tobacco smoke (2001), CRC Press LLC, Boca Raton 177-189
53. Kelsey J.L., and Berkowitz G.S. Breast cancer epidemiology. Cancer Res 48 (1988) 5615-5623
54. Savitz D.A. Interpreting epidemiologic evidence strategies for study design and analysis (2003), Oxford University Press